From: Association between the APOE gene polymorphism and lipid profile and the risk of atrial fibrillation
 | APOE allele groups | AF groups | ANOVA interaction (AF and APOE alleles) | ||||
---|---|---|---|---|---|---|---|
ε2(n = 203) | ε3(n = 758) | ε4(n = 379) | AF (n = 693) | Non-AF (n = 647) | F | P | |
TC (mmol/L) | 3.737(0.075;3.590–3.884) | 4.253(0.039;4.177–4.329) | 4.512(0.055;4.404–4.621) | 4.404(0.047;4.312–4.496) | 3.930(0.048;3.386–4.025) | 6.189 | 0.002 |
TG (mmol/L) | 1.045(0.050;0.947–1.143) | 1.264(0.026;1.214–1.315) | 1.490(0.037;1.417–1.562) | 1.380(0.031;1.319–1.441) | 1.153(0.032;1.090–1.216) | 4.478 | 0.012 |
HDL-C (mmol/L) | 1.275(0.027;1.223–1.327) | 1.240(0.014;1.213–1.267) | 1.188(0.020;1.149–1.226) | 1.248(0.017;1.215–1.280) | 1.221(0.017;1.187–1.254) | 0.214 | 0.808 |
LDL-C (mmol/L) | 1.857(0.053;1.753–1.962) | 2.340(0.028;2.286–2.394) | 2.566(0.039;2.488–2.643) | 2.406(0.033;2.340–2.471) | 2.103(0.034;2.035–2.170) | 3.717 | 0.025 |
Apo-A1 (g/L) | 1.066(0.023;1.020–1.111) | 1.074(0.012;1.050–1.097) | 1.066(0.017;1.033–1.099) | 1.049(0.014;1.021–1.077) | 1.088(0.015;1.059–1.117) | 0.264 | 0.768 |
Apo-B (g/L) | 0.620(0.017;0.587–0.654) | 0.763(0.009;0.745–0.780) | 0.833(0.013;0.808–0.857) | 0.785(0.011;0.764–0.806) | 0.692(0.011;0.670–0.713) | 4.529 | 0.011 |